Cytek Biosciences

Cytek Biosciences

Life Sciences Tools & Services
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

$591.4M

Market Cap • 9/11/2026

2014

(12 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

1,8

P/S

2,9

P/EBITDA

P/OCF

P/FCF

P/E

BVPS

2,5

EPS

Market Cap

Market Cap

591,4M

EV

343,2M

EV/Revenue

1,7

EV/EBITDA

-7,7

EV/EBIT

-7,7

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-132,8M

Profitability

Gross Margin

53,2%

EBITDA Margin

EBIT Margin

Net Margin

D&A/EBITDA

0%

R&D/Revenue

18%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

% PPE

7,1%

% Goodwill

3,7%

ROE

ROIC

Growth

CAGR Revenue 5Y

13,4%

Leverage

N.D./EBITDA

5,6

Debt/Equity

0%

Current Ratio

4,5

Quick Ratio

3,7

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium